SPY332.37-1.82 -0.54%
DIA274.42-1.48 -0.54%
IXIC11,085.25-32.28 -0.29%

Citigroup Maintains Buy on Ovid Therapeutics, Raises Price Target to $10

Citigroup maintains Ovid Therapeutics (NASDAQ:OVID) with a Buy and raises the price target from $9 to $10.

 · 
Citigroup maintains Ovid Therapeutics (NASDAQ:OVID) with a Buy and raises the price target from $9 to $10.